Editorial
doi: 10.1097/AOG.0b013e3181d686ed.
Adnexal masses: when to observe, when to intervene, and when to refer
Affiliations
- PMID: 20308824
- DOI: 10.1097/AOG.0b013e3181d686ed
Item in Clipboard
Editorial
Adnexal masses: when to observe, when to intervene, and when to refer
Obstet Gynecol.
2010 Apr.
No abstract available
Comment in
-
Adnexal masses: when to observe, when to intervene, and when to refer.Obstet Gynecol. 2010 Aug;116(2 Pt 1):440. doi: 10.1097/AOG.0b013e3181ea4f15. Obstet Gynecol. 2010. PMID: 20664410 No abstract available.
Comment on
-
Predicting risk of malignancy in adnexal masses.Obstet Gynecol. 2010 Apr;115(4):687-694. doi: 10.1097/AOG.0b013e3181d44053. Obstet Gynecol. 2010. PMID: 20308826
Similar articles
-
Predicting risk of malignancy in adnexal masses.Obstet Gynecol. 2010 Apr;115(4):687-694. doi: 10.1097/AOG.0b013e3181d44053. Obstet Gynecol. 2010. PMID: 20308826
-
Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.Int J Gynaecol Obstet. 1999 Sep;66(3):255-61. doi: 10.1016/s0020-7292(99)00104-6. Int J Gynaecol Obstet. 1999. PMID: 10580673
-
CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.Int J Biol Markers. 2015 Jul 22;30(3):e333-40. doi: 10.5301/jbm.5000139. Int J Biol Markers. 2015. PMID: 25704505 Review.
-
Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.J Natl Cancer Inst. 2007 Nov 21;99(22):1706-14. doi: 10.1093/jnci/djm199. Epub 2007 Nov 13. J Natl Cancer Inst. 2007. PMID: 18000221
-
Management of adnexal masses in postmenopausal women.Am J Obstet Gynecol. 2005 Jul;193(1):30-5. doi: 10.1016/j.ajog.2005.04.051. Am J Obstet Gynecol. 2005. PMID: 16021055 Review. No abstract available.
Cited by
-
Adnexal masses suspected to be benign treated with laparoscopy.JSLS. 2012 Jan-Mar;16(1):71-84. doi: 10.4293/108680812X13291597716069. JSLS. 2012. PMID: 22906334 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
-
- Fader AN, Rose PG. Role of surgery in ovarian carcinoma. J Clin Onc 2007;25:2873–83.
-
- Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, et al. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2006;102:432–9.
-
- McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, et al. Predicting risk of malignancy in adnexal masses. Obstet Gynecol 2010;115:687–94.
-
- Valentin L, Hagen B, Tingulstad S, Eik-Nes S. Comparison of “pattern recognition” and logistic regression models for discrimination between benign and malignant pelvic masses. A prospective cross-validation. Ultrasound Obstet Gynecol 2001;18:357–65.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
